Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GelStat Arthritis is a topical homeopathic gel formulated for the temporary relief of minor aches and pains associated with arthritis, rheumatism, and joint stiffness. Developed by GelStat Corporation, the product utilizes a combination of traditional homeopathic ingredients, including *Arnica montana*, *Bryonia alba*, *Dulcamara*, *Rhus toxicodendron*, and *Ruta graveolens*. These components are prepared in low decimal dilutions (typically 3X or 6X) and delivered in a gel base intended for local application to affected joints. The mechanism of action is based on homeopathic principles of 'like cures like,' where highly diluted substances are thought to stimulate the body's natural healing response, although it lacks a conventional pharmacological mechanism of action or validated molecular targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GelStat Arthritis.